Comparison between Biopol Chemicals IPO and Rednex Pharmaceuticals IPO.
Biopol Chemicals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Rednex Pharmaceuticals IPO is a SME Bookbuilding proposed to list at BSE SME.
| Biopol Chemicals IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Smart Horizon Capital Advisors Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Biopol Chemicals IPO is up to ₹29.63 Cr whereas the issue size of the Rednex Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Biopol Chemicals IPO is ₹108.00 per share and of Rednex Pharmaceuticals IPO is .
| Biopol Chemicals IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹102.00 per share | |
| Issue Price (Upper) | ₹108.00 per share | |
| Issue Price (Final) | ₹108.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | |
| Fresh Issue Size | 27,43,200 shares | 27,36,000 shares |
| Fresh Issue Size (Amount) | up to ₹29.63 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,43,200 shares | 27,36,000 shares |
| Issue Size Total (Amount) | up to ₹29.63 Cr | up to ₹0.00 Cr |
Biopol Chemicals IPO opens on Feb 06, 2026, while Rednex Pharmaceuticals IPO opens on . The closing date of Biopol Chemicals IPO and Rednex Pharmaceuticals IPO is Feb 10, 2026, and , respectively.
| Biopol Chemicals IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 06, 2026 | |
| Issue Close | Feb 10, 2026 | |
| Basis Of Allotment (Tentative) | Feb 11, 2026 | |
| Initiation of Refunds (Tentative) | Feb 12, 2026 | |
| Credit of Share (Tentative) | Feb 12, 2026 | |
| Listing date (Tentative) | Feb 13, 2026 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Biopol Chemicals IPO P/E ratio is 19.73, as compared to Rednex Pharmaceuticals IPO P/E ratio of .
| Biopol Chemicals IPO | Rednex Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)Rednex Pharmaceuticals Ltd.'s revenue increased by 88% and profit after tax (PAT) rose by 120% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.88 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 19.73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹116.70 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 38.10 | 58.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 30.57 | 23.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.57 | 2.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.47 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 32.00 | 45.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Biopol Chemicals IPO Retail Individual Investors (RII) are offered 9,62,400 shares while in Rednex Pharmaceuticals IPO retail investors are offered 9,62,400 shares. Qualified Institutional Buyers (QIB) are offered 6,86,400 shares in Biopol Chemicals IPO and 0 shares in Rednex Pharmaceuticals IPO.
| Biopol Chemicals IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,51,200 shares | 0 shares |
| QIB | 6,86,400 shares | 0 shares |
| NII | 10,94,400 shares | 0 shares |
| RII | 9,62,400 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 27,43,200 shares | 0 shares |
Biopol Chemicals IPO subscribed 22.33x in total, whereas Rednex Pharmaceuticals IPO subscribed .
| Biopol Chemicals IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 21.05x | |
| NII (times) | 24.49x | |
| Big NII (times) | 27.49x | |
| Small NII (times) | 18.48x | |
| RII (times) | 20.80x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 22.33x |
